Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.82M Sell
502,407
-716,645
-59% -$4.04M ﹤0.01% 1290
2026
Q1
$3.66M Buy
+1,219,052
New +$3.53M ﹤0.01% 1462
2025
Q3
Sell
-612,878
Closed -$1.58M 2836
2025
Q2
$1.58M Buy
+612,878
New +$1.73M ﹤0.01% 1666
2025
Q1
Sell
-1,151,846
Closed -$3.02M 2576
2024
Q4
$3.02M Sell
1,151,846
-152,915
-12% -$538K ﹤0.01% 1285
2024
Q3
$4.98M Sell
1,304,761
-529,141
-29% -$2.1M 0.01% 1003
2024
Q2
$5.65M Buy
1,833,902
+347,079
+23% +$1.61M 0.01% 949
2024
Q1
$8.45M Buy
1,486,823
+1,252,881
+536% +$5.65M 0.01% 803
2023
Q4
$983K Buy
233,942
+122,542
+110% +$227K ﹤0.01% 1485
2023
Q3
$147K Buy
+111,400
New +$195K ﹤0.01% 2009

Other funds holding ABSI

Marshall Wace's ABSI Position: Q2 2026 in Review

Marshall Wace reduced its Absci (ABSI) stake by 59% in Q2 2026, selling an estimated $4.04M and leaving 502,407 shares worth $5.82M. The position accounts for ﹤0.01% of the portfolio, ranked #1290.

Marshall Wace first reported a position in ABSI in Q3 2023 and has held it in 9 quarters since. The position peaked at $8.45M in Q1 2024. 197 funds tracked by Wall St. Rank hold ABSI as of Q2 2026.

  • Marshall Wace held 502,407 shares of Absci worth $5.82M as of Q2 2026.
  • Marshall Wace sold 716,645 Absci shares in Q2 2026, an estimated $4.04M.
  • Absci made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1290 holding.
  • Marshall Wace first reported a position in Absci in Q3 2023 and has held it in 9 quarters since.
  • Marshall Wace's Absci position peaked at $8.45M in Q1 2024.
  • 197 funds tracked by Wall St. Rank held Absci as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.